Statistikk
Totalt antall besøk
Visninger | |
---|---|
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis | 1321 |
Totalt antall besøk pr måned
september 2023 | oktober 2023 | november 2023 | desember 2023 | januar 2024 | februar 2024 | mars 2024 | |
---|---|---|---|---|---|---|---|
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis | 5 | 1 | 5 | 5 | 2 | 220 | 8 |
Nedlastinger av fil
Visninger | |
---|---|
article.pdf | 256 |
Visninger pr land
Visninger | |
---|---|
France | 526 |
United States | 464 |
Germany | 73 |
Sweden | 48 |
Norge | 44 |
Ireland | 33 |
China | 28 |
United Kingdom | 23 |
Portugal | 10 |
Vietnam | 9 |
Visninger pr by
Visninger | |
---|---|
Ashburn | 279 |
Frankfurt am Main | 40 |
Ann Arbor | 33 |
Dublin | 33 |
Southend | 19 |
Oslo | 11 |
Camarate | 10 |
Guangzhou | 7 |
Hanoi | 7 |
Boardman | 5 |